Zynova Tech Launches the Title Industry’s First Automated Workshare Platform for Compliant, Multi-Jurisdictional Order Flow 
Masar Destination Achieves LEED for Communities Gold Certification 
Sir Ivan Releases “Love Is The Piece” COPT to Present at Citi’s 2022 Global Property CEO Conference
COLUMBIA, Md.–(BUSINESS WIRE)–Corporate Office Properties Trust (“COPT” or the “Company”) (NYSE: OFC) announced that its…
C3 AI Announces Fiscal Third Quarter 2022 Financial Results
Revenue Growth of 42% year over year to $69.8 million Raises Guidance to Reflect FY…
AEO Inc. Reports Strong Fourth Quarter and Fiscal 2021 Results; Achieves Fiscal 2023 Goals for Structural Transformation Two Years Ahead of Schedule; Real Power. Real Growth. Plan Positions Company for Long-Term Revenue and Profit Growth
Record Fiscal 2021 Revenue of $5 Billion; Up 33% versus Fiscal 2020 and up 16%…
KLDiscovery Launches Nebula® Partner Program for Service Providers
MCLEAN, Va.–(BUSINESS WIRE)–KLDiscovery, a leading global provider of electronic discovery, information governance and data recovery…
Marchex Announces Fourth Quarter and Full Year 2021 Results
SEATTLE–(BUSINESS WIRE)–Marchex, Inc. (NASDAQ: MCHX), the award-winning AI-powered conversation intelligence company that helps businesses turn…
Vir Biotechnology to Participate in the 42nd Annual Cowen Healthcare Conference
SAN FRANCISCO, March 02, 2022 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…
Fate Therapeutics to Present at Upcoming March Investor Conferences
SAN DIEGO, March 02, 2022 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate…
MDxHealth Reports Financial Year 2021 Results and Provides Outlook and Guidance for 2022
NEWS RELEASE – REGULATED INFORMATION2 MARCH 2022, 4:00 PM EST / 22:00 CET MDxHealth…
Ascendis Pharma A/S Reports Full Year 2021 Financial Results and Provides a Business Update
– Top-line results from PaTHway, a Phase 3 randomized study evaluating the safety, tolerability, and…
Athira Pharma Presents Preclinical Data of Fosgonimeton (ATH-1017) and ATH-1020 at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting
Active metabolite of fosgonimeton (ATH-1017) enhances the HGF/MET system, resulting in neurotrophic and procognitive effects…
Verizon Frontline helped keep first responders connected during Super Bowl LVI
LOS ANGELES, March 02, 2022 (GLOBE NEWSWIRE) — As Los Angeles celebrated a Rams victory…
The Nexus Project Is Excited To Announce Its Most Recent Update, the Nexus Dubai Token
Omniyat, Dubai–(Newsfile Corp. – March 2, 2022) – The Nexus Project is excited to announce…
Esports Entertainment Group Announces Completion of Public Offering of Common Stock and Warrants
Company Raises Net Proceeds of $13.6 Million Hoboken, New Jersey–(Newsfile Corp. – March 2, 2022)…
Everspin Reports Unaudited Fourth Quarter and Full Year 2021 Financial Results
The Company Reports its Best Year in Company History – Profitable Year End Results CHANDLER,…
Nutanix Reports Second Quarter Fiscal 2022 Financial Results
Reports 37% YoY ACV Billings Growth and 19% YoY Revenue Growth Renewals Growth Helps Drive…
Samsara Reports Record Fourth Quarter and Full Fiscal Year 2022 Financial Results
Q4 revenue of $125.8 million, representing 66% year-over-year growth Ending ARR of $558.1 million, representing…
Everspin Announces Appointment of New President and CEO
CHANDLER, Ariz.–(BUSINESS WIRE)–Everspin Technologies, Inc. (NASDAQ: MRAM), the market leader in MRAM, today announced the…
Thanks to the AGIR program, DEINOVE has become a unique French industrial biotech in the fight against antibiotic resistance
Thanks to the AGIR program, DEINOVE has become a unique French industrial biotech in the…
Sorrento Announces COVISHIELD (STI-9199) Antibody Nasal Drops Prevent Productive SARS-CoV-2 Infections When Given 24 Hours Prior to Virus Exposure
STI-9199 neutralizing antibody (nAb) nasal drops prevent productive infections when given to animals 24 hours…
Sorrento Announces FDA Authorization to Proceed With Phase 1 Study Of Intranasal STI-9199 (COVISHIELD), a Potent Neutralization Antibody Against Covid-19 Viruses
FDA granted IND clearance today for STI-9199 (COVISHIELD™) for a Phase 1 safety and pharmacokinetic…